Effect of nitric oxide-releasing aspirin derivative on gastric functional and ulcerogenic responses in rats: Comparison with plain aspirin

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 1, 1998, Pages 115-121

  Takeuchi, Koji ^a   Ukawa, Hideki ^a   Konaka, Akira ^a   Kitamura, Motohiro ^a   Sugawa, Yasunari ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER; ACETYLSALICYLIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG EFFECT; DRUG SCREENING; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; STOMACH FUNCTION; STOMACH MUCOSA; STOMACH PROTECTION; STOMACH ULCER; ULCEROGENESIS;

ANIMALS; ASPIRIN; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; MALE; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; STOMACH ULCER;

EID: 0031819750     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Andrews FJ, Malcontenit-Wilson C and O'Brien PE (1994) Effect of non-steroidal anti-inflammatory drugs on LFA-1 and ICAM-1 expression in gastric mucosa. Am J Physiol 266:G657-G664.
2. Davenport HW (1969) Gastric mucosal hemorrhage in dogs: Effect of acid, aspirin and alcohol. Gastroenterology 56:439-449.
3. Davies NM, Roseth AG, Appleyard CB, McKnight W, Del Soldato P, Calignano A, Cirino G, Wallace JL (1997) NO-naproxen vs. naproxen: Ulcerogenic, analgesic and anti-inflammatory effects. Aliment Pharmocol Ther 11:69-79.
4. Futaki N, Arai I, Hamasaka Y, Takahashi S, Higuchi S, Otomo S (1993) Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air pouch inflammation. J Pharm Pharmacol 45:753-755.
5. Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S and Otomo S (1994) NS-938, a new antiinflammatory agent, selectively inhibits prostaglandin G/H synthase/ cyclo-oxygenase (COX-2) activity in vitro. Prostaglandins 47:55-59.
6. Goddard PJ, Hills BA, Lichtenberger LM (1987) Does aspirin damage canine gastric mucosa by reducing its hydrophobicity? Am J Physiol 252:G421-G430.
7. N-nitrate in biological fluids. Anal Biochem 126:131-138.
8. Hirata T, Ukawa H, Yamakuni H, Kato S, Takeuchi K (1997) Cyclo-oxygenase isozymes in mucosal ulcerogenic and functional responses following barrier disruption in rat stomachs. Br J Pharmacol 122:447-454.
9. Kita Y, Hirasawa Y, Maeda K, Niahio M, Yoshida K (1994) Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409. Eur J Pharmacol 257:123-130.
10. Konturek PK, Brzozowski T, Konturek SJ, Dembinski A (1990) Role of epidermal growth factor, prostaglandin, and sulfhydryls in stress-induced gastric lesions. Gastroenterology 99:1607-1615.
11. Lanza FL (1984) Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal antiinflammatory agents. Am J Med 13:19-24.
12. 2 production. Thromb Haemost 76:791-798.
13. Levy M (1974) Aspirin use in patients with major upper gastrointestinal bleeding and peptic ulcer disease: A report from the Boston Collaborative Drug Surveillance Program. N Eng J Med 290:1159-1162.
14. Lichtenberger ML, Wang ZM, Romero JJ, Ulloa C, Perez JC, Giraud MN and Barreto JC (1995) Non-steroidal anti-inflammatory drugs (NSAIDs) associated with zwitterionic phospholipids: Insight into the mechanism and reversal of NSAID-induced gastrointestinal injury. Nat Med 1:154-158.
15. Ligmusky M, Golanska EM, Hansen DG and Kauffman GL (1983) Aspirin can inhibit gastric mucosal cyclooxygenase without causing lesions in rats. Gastroenterology 84:756-761.
16. MacNaughton WK, Cirino G and Wallace JL (1989) Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach. Life Sci 45:1869-1876.
17. Masferrer JL, Zweifel BS, Manning PA, Hauser SD, Leahy KM, Smith WG, Isakson PC and Seibert K (1994) Selective inhibition of inducible COX-2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci USA 91:3228-3232.
18. Matsumoto J, Takeuchi K, Ueshima K and Okabe S (1992) Role of capsaicinsensitive afferent neurons in mucosal blood flow response of rat stomach induced by mild irritants. Dig Dis Sci 37:1336-1344.
19. McCall T, Whittle BJR, Boughton-Smith NK and Moncada S (1988) Inhibition of fMLP-induced aggregation of rabbit neutrophils by nitric oxide. Br J Pharmacol 95:517P.
20. Moncada S, Palmer RMJ and Higgs EA (1991) Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142.
21. Niida H, Takeuchi K and Okabe S (1991a) Role of thyrotropin-releasing hormone in acid secretory response induced by lowering of body temperature in the rat. Eur J Pharmacol 198:137-142.
22. Niida H, Takeuchi K, Ueshima K and Okabe S (1991b) Vagally-mediated acid hypersecretion and lesion formation in anesthetized rat under hypothermic conditions. Dig Dis Sci 36:441-448.
23. Okabe S, Takeuchi K, Nakamura K and Takagi K (1974) Pathogenesis of gastric lesions induced by aspirin in the pylorus-ligated rats. Jpn J Pharmacol 24:363-371.
24. Robert A (1984) Prostaglandins and the gastrointestinal tract, in Physiology of Gastrointestinal Tract (LR Johnson, J Cristensen, MI Grossman, ED Jacobson and SG Schultz eds) pp 1407-1435, Raven Press, New York.
25. Salvemini D, Wang ZQ, Wyatt PS, Bourdon DM, Marino MH, Manning PP and Currie MG (1996) Nitric oxide: A key mediator in the early and late phases of carrageenan-induced rat paw inflammation. Br J Pharmacol 118:829-838.
26. Takeuchi K, Ohuchi T and Okabe S (1994) Endogenous nitric oxide in gastric alkaline response in the rat stomach after damage. Gastroenterology 106:367-374.
27. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (Lond) 231:232-235.
28. Wallace JL, Keenan C and Granger DN (1990) Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am J Physiol 259:G462-G467.
29. Wallace JL, Reuter B, Cicala C, McKnight W, Grisham M and Cirino G (1994a) Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology 107:173-179.
30. Wallace JL, Reuter B, Cicala C, McKnight W, Grisham M and Cirino G (1994b) A diclofenac derivative without ulcerogenic properties. Eur J Pharmacol 257:249-255.
31. Wallace JL, Cirino G, McKnight G and Elliott SN (1995a) Reduction of gastrointestinal injury in acute endotoxic shock by flurbiprofen nitroxybutylester. Eur J Pharmacol 280:63-68.
32. Wallace JL, McKnight W, Del Soldato P, Baydoun AR and Cirino G (1995b) Antithrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative. J Clin Invest 96:2711-2718.
33. Wallace JL (1997) Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years. Gastroenterology 112:1000-1016.
34. Wallace JL, McKnight W, Wilson TL, Del Soldato P and Cirino G (1997) Reduction of shock-induced gastric damage by a nitric oxide-releasing aspirin derivative: Role of neutrophils. Am J Physiol 273:G1246-G1251.
35. Whittle BJR (1983) The potentiation of taurocholate-induced rat gastric erosions following parenteral administration of cyclooxygenase inhibitor. Br J Pharmacol 80:545-551.
36. Whittle BJR, Lopez-Belmonte J and Moncada S (1990) Regulation of gastric mucosal integrity by endogenous nitric oxide: Interactions with prostaglandins and sensory neuropeptides in the rat. Br J Pharmacol 99:607-611.
37. Yoshida N, Granger DN and Anderson DC (1993) Molecular determinants of aspirininduced neutrophil adherence to endothelial cells. Gastroenterology 105:1431-1440.